Annual Total Long Term Liabilities
$0.00
-$408.00 K-100.00%
31 December 2023
Summary:
Day One Biopharmaceuticals annual total long term liabilities is currently $0.00, with the most recent change of -$408.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$92.17 million (-100.00%). DAWN annual total long term liabilities is now -100.00% below its all-time high of $92.17 million, reached on 31 December 2020.DAWN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$5.60 M
+$5.60 M+100.00%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly total long term liabilities is currently $5.60 million, with the most recent change of +$5.60 million (+100.00%) on 30 September 2024. Over the past year, it has increased by +$5.52 million (+7171.43%). DAWN quarterly long term liabilities is now -97.48% below its all-time high of $221.88 million, reached on 31 March 2021.DAWN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +7171.4% |
| 3 y3 years | -100.0% | +8513.9% |
| 5 y5 years | - | - |
DAWN Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at high | ||
| 5 y | 5 years | -100.0% | -97.5% | ||
| alltime | all time | -100.0% | -97.5% |
Day One Biopharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.60 M(>+9900.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2023 | - | $77.00 K(-59.5%) |
| June 2023 | - | $190.00 K(-36.7%) |
| Mar 2023 | - | $300.00 K(-26.5%) |
| Dec 2022 | $408.00 K | $408.00 K(-20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $514.00 K(-16.7%) |
| June 2022 | - | $617.00 K(>+9900.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $16.00 K(-100.0%) | $16.00 K(-75.4%) |
| Sept 2021 | - | $65.00 K(-42.0%) |
| June 2021 | - | $112.00 K(-99.9%) |
| Mar 2021 | - | $221.88 M(+140.7%) |
| Dec 2020 | $92.17 M(+202.2%) | $92.17 M |
| Dec 2019 | $30.50 M | - |
FAQ
- What is Day One Biopharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual total long term liabilities year-on-year change?
- What is Day One Biopharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly long term liabilities year-on-year change?
What is Day One Biopharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of DAWN is $0.00
What is the all time high annual total long term liabilities for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual total long term liabilities is $92.17 M
What is Day One Biopharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, DAWN annual total long term liabilities has changed by -$408.00 K (-100.00%)
What is Day One Biopharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of DAWN is $5.60 M
What is the all time high quarterly long term liabilities for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly total long term liabilities is $221.88 M
What is Day One Biopharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, DAWN quarterly total long term liabilities has changed by +$5.52 M (+7171.43%)